Keynote lecture: Focus on new tests and techniques by Katrien Devreese

Keynote lecture: APS: It's far more than you think by Richard Furie

Keynote lecture: Updating of APS pathophysiology: does it impact on clinical management? by Pier-Luigi Meroni

Risk stratification and scoring system models in APS by Savino Sciascia

Pitfalls in the organization of an APS multicenter study by Ricard Cervera

Antiphospholipid antibody-induced cellular responses depend on epitope specificity by Karl Lackner

LAC results APS ACTION by Maria Efthymiou

A multicenter study to determine obstetrical outcome and treatments during pregnancy in seronegative primary APS by Arsene Mekinian

The role of platelets and thrombocytopenia in APS by Vittorio Pengo

Anti-b2glycoprotein I antibodies of the IgA isotype recognize epitopes in domain 3, 4 and 5 that are located in the same lateral zone of the molecule by Manuel Serrano

Use of direct oral anticoagulant in APS: systematic review of literature by Virginie Dufrost

Microparticles in APS by Elisabet Svenungsson

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid carriers by Ariela Hoxha

Immune complexes of b2glycoprotein I in patients with IgA antiphospholipid antibodies identify patients with elevated risk of early mortality after heart transplantation by Manuel Serrano

Lipids in APS by Coen Hemker

Presence of immune complexes of IgG/IgM bound to b2glycoprotein I is associated with non-criteria manifestations in APS by Ljudmila Stojanovich

New insight into APS: antibodies to b2glycoprotein I-domain V fail to induce thrombi in rats by Claudia Grossi

Antiphospholipid antibodies in SLE define a subset of patients with hematological abnormalities and greater damage accrual by Enrico Fuzzi

Complement activation in APS: evaluation of platelet-bound C4d in ex vivo and in vitro studies by Paola Adele Lonati

Mental disorders in secondary APS patients by Tatiana Lisitsyna